Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Call to Action for Dengue Vacc...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Call to Action for Dengue Vaccine Failure

Call to Action for Dengue Vaccine Failure

Bibliographic Details
Main Authors: Suresh Mahalingam, Belinda L. Herring, Scott B. Halstead
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2013-08-01
Series:Emerging Infectious Diseases
Subjects:
dengue virus
dengue
viruses
vaccine
vaccine failure
antibody-dependent enhancement of infection
Online Access:https://wwwnc.cdc.gov/eid/article/19/8/12-1864_article
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:1080-6040
1080-6059

Similar Items

  • Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine
    by: Rahul Shukla, et al.
    Published: (2020-10-01)
  • Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection
    by: Tomohiro Kotaki, et al.
    Published: (2022-08-01)
  • Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
    by: Scott B. Halstead
    Published: (2018-09-01)
  • Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity
    by: Jisang Park, et al.
    Published: (2020-02-01)
  • Safety and immunogenicity of a single dose, live-attenuated ‘tetravalent dengue vaccine’ in healthy Indian adults; a randomized, double-blind, placebo controlled phase I/II trial
    by: Lalitendu Mohanty, et al.
    Published: (2022-04-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs